Efficacy and Safety of Direct-Acting Antivirals in Hepatitis C Virus-Infected Patients Taking Proton Pump Inhibitors

被引：0

作者：

Wijarnpreecha, Karn ^{[1
]}

Chesdachai, Supavit ^{[2
]}

Thongprayoon, Charat ^{[1
]}

Jaruvongvanich, Veeravich ^{[3
]}

Ungprasert, Patompong ^{[4
]}

Cheungpasitporn, Wisit ^{[4
]}

机构：

[1] Bassett Med Ctr, Internal Med, Cooperstown, NY USA

[2] Mahidol Univ, Ramathibodi Hosp, Fac Med, Med, Bangkok, Thailand

[3] Univ Hawaii, Internal Med, Honolulu, HI 96822 USA

[4] Mayo Clin, Med, Rochester, MN USA

来源：

HEPATOLOGY | 2017年 / 66卷

关键词：

D O I：

暂无

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

1163

引用

页码：625A / 625A

页数：1

共 50 条

[31] Hepatitis C virus resistance to the new direct-acting antivirals
Esposito, Isabella
Trinks, Julieta
Soriano, Vicente
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (10) : 1197 - 1209
[32] EFFICACY AND TOLERABILITY OF DIRECT-ACTING ANTIVIRALS IN HEMODIALYSIS PATIENTS WITH CHRONIC HEPATITIS C
Tomanoski, Vasilije
Gjorgjievska, Gordana
Krecova, Vasiliki
Nakovska, Margarita
Andonoski, Aleksandar
Zvezdakovska, Jasminka
Kachakova, Angela
Kepeska-Atanasovska, Sintia
Micajkova, Marija
Veliu, Ramazan
Ferati, Bejane
Tomanoska, Ana
Zabzun, Zana
Borisova, Irena
Kjamili, Gojard
Kjamili, Merima
Izairi, Shpresa
Jagupi, Shpresim
Veseli, Leonora
Trifunovska, Nada
Matevska, Adriana
Ristevska, Tatjana
Lozanoski, Davor
Dimova, Katerina
Stojanova, Elena
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2023, 38 : I839 - I840
[33] Effectiveness of direct-acting antivirals in Hepatitis C virus infection in haemodialysis patients
Abad, Soraya
Vega, Almudena
Rincon, Diego
Hernandez, Eduardo
Merida, Evangelina
Macias, Nicolas
Munoz, Raquel
Milla, Monica
Luno, Jose
Manuel Lopez-Gomez, Juan
NEFROLOGIA, 2017, 37 (02): : 158 - 163
[34] Impact of All-Oral Direct-Acting Antivirals on Clinical and Economic Outcomes in Chronic Hepatitis C Virus-Infected Patients in the US
Park, Haesuk
Wang, Wei
Henry, Linda
Nelson, David R.
HEPATOLOGY, 2018, 68 : 92A - 92A
[35] Safety and Efficacy of Direct-Acting Antivirals in Transfusion-Dependent Thalassemic Patients with Chronic Hepatitis C
Onali, Simona
Maida, Ivana
Balestrieri, Cinzia
Arcadu, Francesco
Urru, Enrico
Porcu, Davide
Serra, Giancarlo
Flore, Giacomo
Dore, Elena
Satta, Caterina
Bitti, Pier Paolo
Sanna, Maria Grazia
Serusi, Loredana
Casale, Michele
Conti, Maria
Loi, Martina
Figorilli, Francesco
Pasetto, Maria Cristina
Babudieri, Sergio
Chessa, Luchino
HEPATITIS MONTHLY, 2018, 18 (01)
[36] Efficacy of direct-acting antivirals in patients with hepatitis C virus-associated cryoglobulinemia and monoclonal gammopathy
Gavrisheva, Sofiia
Abdurakhmanov, Dzhamal
Bulanov, Nikolay
Krasnova, Tatiana
Tanashchuk, Elena
Rozina, Teona
Nikulkina, Elena
Milovanova, Svetlana
Filatova, Anna
Moiseev, Sergey
JOURNAL OF HEPATOLOGY, 2023, 78 : S1210 - S1210
[37] Real-World Efficacy and Safety of Pangenotypic Direct-Acting Antivirals Against Hepatitis C Virus Infection
Scotto, Riccardo
Buonomo, Antonio Riccardo
Moriello, Nicola Schiano
Maraolo, Alberto Enrico
Zappulo, Emanuela
Pinchera, Biagio
Gentile, Ivan
Borgia, Guglielmo
REVIEWS ON RECENT CLINICAL TRIALS, 2019, 14 (03) : 173 - 182
[38] Benefits of Direct-Acting Antivirals for Hepatitis C
Lok, Anna S.
Chung, Raymond T.
Vargas, Hugo E.
Kim, Arthur Y.
Naggie, Susanna
Powderly, William G.
ANNALS OF INTERNAL MEDICINE, 2017, 167 (11) : 812 - +
[39] Targeting Hepatitis C With Direct-Acting Antivirals
Pennell, Laurie
LaPreze, Jennifer
US PHARMACIST, 2023, 48 (03) : 22 - 27
[40] The impact of unrestricted access to direct-acting antiviral among incarcerated hepatitis C virus-infected patients
Wong, Yu Jun
Thurairajah, Prem Harichander
Kumar, Rahul
Fock, Kwong Ming
Law, Ngai Moh
Chong, Sin-Yoong
Manejero, Fria Gloriba
Ang, Tiing-Leong
Teo, Eng Kiong
Tan, Jessica
CLINICAL AND MOLECULAR HEPATOLOGY, 2021, 27 (03) : 474 - 485

← 1 2 3 4 5 →